Status:
COMPLETED
Surgeon Experience ReSTOR A +4 Intraocular Lens (IOL)
Lead Sponsor:
Alcon Research
Conditions:
Cataract
Eligibility:
All Genders
18+ years
Brief Summary
To collect visual outcome data post AcrySof ReSTOR Aspheric +4 implantation from surgeons throughout the United States.
Eligibility Criteria
Inclusion
- operable cataracts; candidate for presbyopic correcting intraocular lens (IOL)
Exclusion
- ocular comorbidities confounding study outcomes
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT00733512
Start Date
June 1 2007
End Date
March 1 2008
Last Update
March 27 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alcon Call Center for Trial Locations
Fort Worth, Texas, United States, 76134